San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, NanoCellect Biomedical is raising $20,000,001.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Chris Neary played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NanoCellect Biomedical
NanoCellects mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. NanoCellects game changing technology offers unique solutions to barriers imposed by current state of the art flow cytometers. We use microfluidics with an integrated sorting system that immensely simplifies the process of analyzing and sorting distinct populations of cells from a heterogeneous population.

To learn more about NanoCellect Biomedical, visit http://www.nanocellect.com/

Contact:
Chris Neary, Chief Executive Officer
877-745-7678
chris.neary@nanocellect.com
https://www.linkedin.com/in/chris-neary-9a1567/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved